Just a few days back we discussed that the stock price of Merck is being weighed down due to concerns around its Covid-19 antiviral pill - Molnupiravir - which has an efficacy of 30% against hospitalization and death in high-risk patients. Yesterday, a panel of advisors to the U.S. FDA voted in...
Just a few days back we discussed that the stock price of Merck is being weighed down due to concerns around its Covid-19 antiviral pill - Molnupiravir - which has an efficacy of 30% against hospitalization and death in high-risk patients. Yesterday, a panel of advisors to the U.S. FDA voted in...
Share this Article
Recommended